Position in EXEL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,446,926
+$436,286 QoQ
Shares Held
44,972
-4.1% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#242
of 751 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Elo Mutual Pension Insurance Co holds $44,287,438 across 9 Biotechnology names. EXEL ranks #7 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
33,374 | $16,577,867 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,957 | $8,079,207 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
16,446 | $4,950,739 | |
| 4 | INCY |
Incyte Corp
|
39,667 | $4,496,651 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
45,119 | $3,531,464 | |
| 6 | RPRX |
Royalty Pharma plc
|
47,082 | $2,639,887 | |
| 7 | EXEL |
Exelixis, Inc.
This page
|
44,972 | $2,446,926 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
23,025 | $1,317,490 |
All Filings in EXEL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,446,926 | 44,972 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,010,640 | 46,879 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,376,331 | 54,217 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,256,755 | 54,643 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,073,965 | 24,364 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $552,064 | 14,953 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $605,993 | 18,198 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||